Skip to main content

Table 4 Multivariate analysis for luminal types (IDC, ILC)

From: Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma

 

DFS

OS

Variables

HR (95 % CI)

P-value

HR (95 % CI)

P-value

Age

    

50

1.0

 

1.0

 

  < 50

1.32(0.88–1.99)

0.176

1.60(0.79–3.25)

0.184

Tumor size

    

  < 2

1.0

 

1.0

 

 2 ≤ T < 5

2.35(1.49–3.71)

 

3.85(1.79–8.26)

 

 5≥

4.04(2.11–7.73)

<0.001

5.84(1.65–14.15)

<0.001

Lymph node status

    

 Negative

1.0

 

1.0

 

 Positive

2.28(1.37–3.79)

0.001

3.06(1.39–8.15)

0.010

Pathology type

    

 IDC

1.0

 

1.0

 

 ILC

2.49(1.28–4.85)

0.009

1.90(0.63–5.74)

0.262

Histological grade

    

 1

1.0

 

1.0

 

 2

1.77(1.01–3.10)

 

1.51(0.58–3.91)

 

 3

2.31(1.22–4.38)

0.009

2.44(0.87–6.81)

0.060

Endocrine therapy

    

 No

1.0

 

1.0

 

 Yes

0.40(0.25–0.70)

0.002

0.35(0.15–0.82)

0.017

Chemotherapy

    

 No

1.0

 

1.0

 

 Yes

1.29(0.74–2.25)

0.320

1.02(0.42–2.50)

0.745

  1. IDC invasive ductal carcinoma, ILC invasive lobular carcinoma DFS disease free survival, OS overall survival, HR hazard ratio, 95%CI 95 % confidence interval